Bob Rosenbluth, Ph.D.
Co-Founder & Chairman of the Board
Bob has an extensive background of leadership, innovation, and entrepreneurship in the medical device industry. Bob was a founder of Okami Medical and served as its CEO through 2023. Bob is also a founder of Inceptus Medical, a medical device incubator founded in 2011. Inceptus Medical incubated Inari Medical (NASDAQ: NARI), where Bob was a founder of Inari Medical, serving as President and CEO from its inception in 2011 through 2015 and as Chairman of the Board from inception until its IPO in May 2020. Prior to Inceptus and Inari, Bob was a founder, CEO, and Chairman of Sequent Medical. Sequent was acquired by Terumo Medical Corporation in 2016 for $380M. Before Sequent, Bob was a founder of MicroVention, serving as President and CEO from its inception in 1997 through 2002 and as Chairman of the Board from inception until its acquisition by Terumo. Prior to founding MicroVention, he founded Advanced Surgical Intervention and served as President and CEO from its inception through its acquisition by Uromed in 1996. Bob also served in various R&D, business development and senior management positions at Medtronic, Pfizer/Shiley, and Cardiothoracic Systems. He holds a B.S. in Chemical Engineering from Columbia University, an M.S. in Chemical Engineering, and a Ph.D. in Mechanical Engineering from University of California, Berkeley. Bob is the recipient of the 2023 Phoenix Conference Innovator award for his contributions to MedTech innovation.
Rhonda Robb
President, Chief Executive Officer & Board Member
Rhonda was most recently Chief Operating Officer at Cardiovascular Systems, Inc. In that role she was responsible for the general management of the Company and for the operating systems and structures to ensure execution of the Company’s key strategies and initiatives for growth and international expansion. Rhonda led US Sales, International, Marketing, Health Economics, Reimbursement, Product Development, Clinical Affairs, Quality, Regulatory Affairs and the Information Technology functions. Prior to CSI, she was Vice President and General Manager for the Structural Heart Business at Medtronic, where she provided leadership for the transcatheter heart valve and surgical heart valve franchises. Rhonda held additional leadership positions at Medtronic in the Cardiac & Vascular space in Interventional Cardiology and in Cardiac Rhythm and Heart Failure with leadership roles in strategic marketing, market development, business/commercial leadership, strategy, portfolio development and education. She also serves on the Board of 4C Medical. Rhonda earned a Bachelor’s Degree from the University of Minnesota and a Master’s Degree in Business Administration from the Carlson School of Business, at the University of Minnesota.
Donald Milder
Board Member
Donald Milder has served as a member of our board of directors since 2017. In 1999, Mr. Milder co-founded Versant Venture Management, LLC, or Versant, where he has been a Managing Director since its inception. Versant is a venture capital firm that invests in medical devices, biotechnology, life science, pharmaceuticals and healthcare sectors. Previously, Mr. Milder was a Managing Director with CPVP Management LP from August 1989 to November 1999, where he was responsible for their healthcare investments. Prior to this, Mr. Milder was the Chief Executive Officer of Infusion Systems Corporation from 1984 to 1989. He currently serves as Chairman of the Board of Inari Medical, Inc. (NASDAQ: NARI) and as a board member for Eclipse Regenesis, Inc., NeoSeq Ltd. and Ceres Foundation. Mr. Milder received a B.A. from Union College and an M.B.A. from Harvard Business School.
Jonathan Root, M.D.
Board Member
Jonathan Root, M.D. has served as a member of our board of directors since 2017. Dr. Root has served as Managing Member of Presidio Management Group, LLC and several U.S. Venture Partners’ funds since 1998. Dr. Root currently serves on the boards of Inari Medical, Inc. (NASDAQ: NARI), a leading medical device company focused on the treatment of venous thromboembolism, chronic venous disease and chronic limb threatening ischemia, and Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a clinical stage biopharmaceutical company focused on treating severe, rare muscle disorders and hypertrophic cardiomyopathy. Dr. Root also serves on the board of directors of several private companies in the healthcare industry. Dr. Root received an A.B. from Dartmouth College, an M.D. from University of Florida, College of Medicine and an M.B.A. from Columbia Business School.
Paul Lubock
Co-Founder, Vice President & Board Member
Paul is a Principal and a founder of Inceptus Medical, a medical device incubator founded in 2011. At Inceptus, he was a founder of Inari Medical (NASDAQ: NARI) and served a Vice President until 2017 and on the Board of Directors from 2011 until 2020. Prior to Inceptus and Inari, he was a founder of SenoRx, which was acquired by C.R. Bard for $213M. He served as Chief Technical Officer from 1999 and Senior Vice President from April 2009 until his departure in 2011. Paul also served on the Board of Directors from 1998 to 2001 and served as Chief Operating Officer from 1998 to 1999. Prior to 1998, Paul was a founder and President of Abacus Design & Development, a medical product development company, and the founder of Laparomed, which was acquired by Advanced Surgical. Paul held various positions at Laparomed, including President, Vice President of Engineering and served on its Board of Directors. Previously he was Vice President of Engineering at Medstone and held engineering management roles at Shiley/Pfizer and Thoratec. Paul holds over 198 issued U.S. patents. He earned his B.A. in Applied Mechanics and Engineering Science from the University of California, San Diego and his M.S. in Mechanical Engineering from the University of California, Berkeley.
Brian Cox
Co-Founder & Board Member
Brian is a founder of Inceptus Medical, a medical device incubator founded in 2011. At Inceptus, he was a founder of Inari Medical (NASDAQ: NARI) and Okami Medical. Prior to Inceptus and Inari, Brian was a founder of Sequent Medical where he served as Vice President and Chief Technical Officer. Sequent was acquired by Terumo Medical Corporation for $380M. Prior to Sequent, Brian was a founder of MicroVention which was acquired by Terumo. At MicroVention, Brian served as Vice President of Business and Technology Development. Prior to MicroVention, Brian was Engineering Manager at AneuRx, which was acquired by Medtronic. Prior to AneuRx, he held various managerial and technical positions with Advanced Surgical Intervention, Allergan Medical Optics, and Shiley/Pfizer. He earned a B.S. in mechanical engineering from Oregon State University and a M.B.A. from Pepperdine University. Brian is an inventor on over 100 issued U.S. and international patents.